Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
223 Views
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
250 Views
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
364 Views
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
428 Views
A Growing Market, Government Backing: What's Not to Like?
China Traditional Chinese Medicine (570 HK) is an intriguing vehicle to participate in both the growth and the consolidation of China's TCM market....
340 Views